Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe.
about
The 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected KoreansHarnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosisAntiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaRetention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in MalawiGlobal response to HIV: treatment as prevention, or treatment for treatment?Antiretroviral therapy for tuberculosis control in nine African countries.HIV treatment as prevention: optimising the impact of expanded HIV treatment programmesMissed opportunities: poor linkage into ongoing care for HIV-positive pregnant women in Mwanza, Tanzania.Integration of HIV care into maternal health services: a crucial change required in improving quality of obstetric care in countries with high HIV prevalence.Increasing incidence of pregnancy among women receiving HIV care and treatment at a large urban facility in western Uganda.Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?Implementation and Operational Research: Barriers and Facilitators to Combined ART Initiation in Pregnant Women With HIV: Lessons Learnt From a PMTCT B+ Pilot Program in Swaziland.Act local, think global: how the Malawi experience of scaling up antiretroviral treatment has informed global policy.Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and updateModelling the impact of antiretroviral therapy on the epidemic of HIVCost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in ZimbabweRetention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort studyFertility desires, unmet need for family planning, and unwanted pregnancies among HIV-infected women in care in Kinshasa, DR Congo.Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.The 2013 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans.CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa.Reproductive and maternal healthcare needs of HIV infected women.Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.Pursuing ethical coherence in the prevention of vertical transmission of HIV: justice and injustice in Option BUniversal antiretroviral therapy among pregnant and postpartum HIV-infected women would improve maternal health and decrease postnatal HIV transmission.Editorial commentary: turning the tide on HIV in women and children: preventing breast-milk HIV transmission while increasing maternal life expectancy.UNICEF's contribution to the adoption and implementation of option B+ for preventing mother-to-child transmission of HIV: a policy analysis.
P2860
Q26781379-7D2E0ED1-D60C-42D4-AACA-93EEF3F2F08AQ26828443-57D26635-FE04-4459-8A70-3D34C747DC96Q27014960-5105CCA9-4E8E-4CDE-ADAA-6B3EB5ED3C6DQ33563656-CFF047DA-7F29-4CE3-A039-EE187D455375Q34077723-2834272A-D562-4D32-B617-E0D49C4F00FBQ34320245-CD929004-1528-4D4C-9F93-7F5F58253FBDQ34339517-70C58F95-7B1A-4A82-8999-8C666E3E86FDQ34341774-1A5D840A-5BB2-4FE2-AE52-75A5B0F41019Q34768678-59CAB507-4D72-4758-B789-7461639DA60CQ35191076-1AA62CFB-F393-4653-90E6-F8382A9AFFC3Q35557314-FA578CBB-AF54-45B0-9A43-3771F7AB23C3Q35566705-FBFCF5AE-93FC-43CD-9D4B-E83F049333C4Q36124634-1EC6C8D9-6B21-47AE-876C-445564ACD352Q36221392-51E9BC33-0E15-4D70-9A02-33B20216CBBFQ36411097-BC9811FD-2C60-45CA-AAFE-753A38C7E5EFQ36486234-464158E2-1BB6-426E-BF91-442583F076FFQ36517778-C2DBF2CE-29AF-4C31-8269-020F625D59C5Q36995825-10FE3FA2-7E37-437A-938B-FE13D82A7BBBQ37035006-25138071-D26D-4413-BCFC-F34DB6F1F075Q37483442-4C73BCF5-1A65-447A-B8E7-7369339101C7Q37518294-0BF4675A-AFFC-4B9E-9883-4030AA20A0F3Q37578941-6376FED8-6420-4448-854A-DD13CF625BB9Q38126891-B951422C-EC83-4DFB-987E-74F0191029B8Q38865880-CAFC8560-44F6-460D-8C27-0FB1BFAA3F35Q40440550-6FE00F0C-50B0-4001-B041-04F0ED46F3FEQ42334795-19E4FEA7-9A00-46A5-8A80-2E5B5DD02BD3Q42755393-FD39E2AF-6426-4A14-846B-848329154793Q44316398-57CE3C14-E45E-4C7B-8229-1F0B80B9FC4BQ55077885-46CE5762-0067-4996-BDDE-DF73DAFA4E3C
P2860
Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe.
@en
Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe.
@nl
type
label
Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe.
@en
Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe.
@nl
prefLabel
Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe.
@en
Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe.
@nl
P2093
P921
P1433
P1476
Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe.
@en
P2093
Jean H Humphrey
John W Hargrove
ZVITAMBO Study Group
P356
10.1097/QAD.0B013E328335749D
P407
P577
2010-01-01T00:00:00Z